[BREAKING] Rivoceranib NDA Drug Permit Application Completed The Birth of Korea's First New Test of Anti-Cancer Drug

7 November Share

[BREAKING] Rivoceranib NDA Drug Permit Application Completed The Birth of Korea's First New Test of Anti-Cancer Drug

[単独]リボセラニブNDA薬物許可申請完了、韓国初の抗癌新薬誕生か

[独家] NDA 药物许可申请完成 能否诞生大韩民国首个抗癌新药

Разрешение на лекарства от NDA для Livocerani NDA завершилось после того, как станет первым зарождением антираковой терапии в Республике Корея.

[단독] 리보세라닙 NDA 약물허가 신청 완료 대한민국 최초 항암 신약 탄생하나 [More News]